Do we really want to REACH out to in vitro?

NeuroToxicology

Volumn 39, Issue , 2013, Pages 169-172

  Westerink, Remco H S ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

In vitro neurotoxicity; PC12 cells; SH SY5Y cells; Testing strategies

Indexed keywords

CATECHOLAMINE; DOPAMINE BETA MONOOXYGENASE; HYDROCARBON; ORGANOPHOSPHATE INSECTICIDE; POLYCHLORINATED BIPHENYL; VOLTAGE GATED CALCIUM CHANNEL;

BIOLOGICAL MODEL; CATECHOLAMINE SYNTHESIS; CELL CLONING; CELL STRAIN; CELL STRAIN SH SY5Y; CELL VIABILITY; CYTOTOXICITY; ENVIRONMENTAL FACTOR; HUMAN; IN VITRO STUDY; LEGAL ASPECT; MEDICAL RESEARCH; NEUROBLASTOMA CELL; NEUROTOXICITY; NEUROTOXICOLOGY; NONHUMAN; NOTE; PC12 CELL; POLLUTANT; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SYMPATHETIC NERVE CELL; TOXICITY TESTING;

IN VITRO NEUROTOXICITY; PC12 CELLS; SH-SY5Y CELLS; TESTING STRATEGIES;

ANIMAL TESTING ALTERNATIVES; ANIMALS; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; HUMANS; REGISTRIES; SCIENCE; TOXICITY TESTS;

EID: 84886852970     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2013.10.001     Document Type: Note

References (43)

1. Bal-Price A.K., Hogberg H.T., Buzanska L., Lenas P., van Vliet E., Hartung T. In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints. Neurotoxicology 2010, 31:545-554.
2. Bal-Price A.K., Suñol C., Weiss D.G., van Vliet E., Westerink R.H., Costa L.G. Application of in vitro neurotoxicity testing for regulatory purposes: symposium III summary and research needs. Neurotoxicology 2008, 29:520-531.
3. Berghuis S.A., Soechitram S.D., Hitzert M.M., Sauer P.J., Bos A.F. Prenatal exposure to polychlorinated biphenyls and their hydroxylated metabolites is associated with motor development of three-month-old infants. Neurotoxicology 2013, 10.1016/j.neuro.2013.07.003.
4. Chen L., Huang E., Wang H., Qiu P., Liu C. RNA interference targeting α-synuclein attenuates methamphetamine-induced neurotoxicity in SH-SY5Y cells. Brain Res 2013, 1521:59-67.
5. Cheung Y.T., Lau W.K., Yu M.S., Lai C.S., Yeung S.C., So K.F., et al. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 2009, 30:127-135.
6. Choong C.J., Say Y.H. Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P A53T and E46K. Neurotoxicology 2011, 32:857-863.
7. Costa L.G., Giordano G. Developmental neurotoxicity of polybrominated diphenyl ether (PBDE) flame retardants. Neurotoxicology 2007, 28:1047-1067.
8. Costa L.G., Giordano G. Is decabromodiphenyl ether (BDE-209) a developmental neurotoxicant?. Neurotoxicology 2011, 32:9-24.
9. de Groot M.W., Westerink R.H., Dingemans M.M. Don't judge a neuron only by its cover: neuronal function in in vitro developmental neurotoxicity testing. Toxicol Sci 2013, 132:1-7.
10. Dingemans M.M., Heusinkveld H.J., de Groot A., Bergman A., van den Berg M., Westerink R.H. Hexabromocyclododecane inhibits depolarization-induced increase in intracellular calcium levels and neurotransmitter release in PC12 cells. Toxicol Sci 2009, 107:490-497.
11. Dingemans M.M., van den Berg M., Westerink R.H. Neurotoxicity of brominated flame retardants: (in)direct effects of parent and hydroxylated polybrominated diphenyl ethers on the (developing) nervous system. Environ Health Perspect 2011, 119:900-907.
12. Duman J.G., Chen L., Hille B. Calcium transport mechanisms of PC12 cells. J Gen Physiol 2008, 131:307-323.
13. Fox D.A., Opanashuk L., Zharkovsky A., Weiss B. Gene-chemical interactions in the developing mammalian nervous system: effects on proliferation, neurogenesis and differentiation. Neurotoxicology 2010, 31:589-597.
14. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976, 73:2424-2428.
15. Hissink A.M., Krüse J., Kulig B.M., Verwei M., Muijser H., Salmon F., et al. Model studies for evaluating the neurobehavioral effects of complex hydrocarbon solvents III. PBPK modeling of white spirit constituents as a tool for integrating animal and human test data. Neurotoxicology 2007, 28:751-760.
16. A receptor function: a novel mode of action of drugs of abuse. Neurotoxicology 2011, 32:823-827.
17. Huang H., Bihaqi S.W., Cui L., Zawia N.H. In vitro Pb exposure disturbs the balance between Aβ production and elimination: the role of AβPP and neprilysin. Neurotoxicology 2011, 32:300-306.
18. Johnstone A.F., Gross G.W., Weiss D.G., Schroeder O.H., Gramowski A., Shafer T.J. Microelectrode arrays: a physiologically based neurotoxicity testing platform for the 21st century. Neurotoxicology 2010, 31:331-350.
19. Kim K.H., Bose D.D., Ghogha A., Riehl J., Zhang R., Barnhart C.D., et al. Para- and ortho-substitutions are key determinants of polybrominated diphenyl ether activity toward ryanodine receptors and neurotoxicity. Environ Health Perspect 2011, 119:519-526.
20. 2+ buffering in rat cerebellum by hydroxylated polychlorinated biphenyls. Neurotoxicology 2003, 24:187-198.
21. Kumar K.K., Aboud A.A., Bowman A.B. The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk. Neurotoxicology 2012, 33:518-529.
22. Llorens J., Li A.A., Ceccatelli S., Suñol C. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it. Neurotoxicology 2012, 33:796-804.
23. McConnell E.R., McClain M.A., Ross J., Lefew W.R., Shafer T.J. Evaluation of multi-well microelectrode arrays for neurotoxicity screening using a chemical training set. Neurotoxicology 2012, 33:1048-1057.
24. Ou X.M., Partoens P.M., Wang J.M., Walker J.H., Danks K., Vaughan P.F., et al. The storage of noradrenaline, neuropeptide Y and chromogranins in and stoichiometric release from large dense cored vesicles of the undifferentiated human neuroblastoma cell line SH-SY5Y. Int J Mol Med 1998, 1:105-112.
25. 2+ channel complex type 1 (RyR1). Chem Res Toxicol 2006, 19:92-101.
26. Pöltl D., Schildknecht S., Karreman C., Leist M. Uncoupling of ATP-depletion and cell death in human dopaminergic neurons. Neurotoxicology 2012, 33:769-779.
27. Pothos E., Desmond M., Sulzer D. L-3,4-dihydroxyphenylalanine increases the quantal size of exocytotic dopamine release in vitro. J Neurochem 1996, 66:629-636.
28. Radio N.M., Mundy W.R. Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology 2008, 29:361-376.
29. Shafer T.J., Atchison W.D. Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicology 1991, 12:473-492.
30. Song C., Kanthasamy A., Jin H., Anantharam V., Kanthasamy A.G. Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration. Neurotoxicology 2011, 32:586-595.
31. Song X., Ehrich M. Alterations of cytoskeletal tau protein of SH-SY5Y human neuroblastoma cells after exposure to MPTP. Neurotoxicology 1998, 19:73-81.
32. Stenberg M., Hamers T., Machala M., Fonnum F., Stenius U., Lauy A.A., et al. Multivariate toxicity profiles and QSAR modeling of non-dioxin-like PCBs - an investigation of in vitro screening data from ultra-pure congeners. Chemosphere 2011, 85:1423-1429.
33. Tilson H.A., Kodavanti P.R. The neurotoxicity of polychlorinated biphenyls. Neurotoxicology 1998, 19:517-525.
34. Timchalk C., Poet T.S. Development of a physiologically based pharmacokinetic and pharmacodynamic model to determine dosimetry and cholinesterase inhibition for a binary mixture of chlorpyrifos and diazinon in the rat. Neurotoxicology 2008, 29:428-443.
35. Tischler A.S., Perlman R.L., Morse G.M., Sheard B.E. Glucocorticoids increase catecholamine synthesis and storage in PC12 phaeochromocytoma cell cultures. J Neurochem 1983, 40:364-370.
36. van Thriel C., Westerink R.H., Beste C., Bale A.S., Lein P.J., Leist M. Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts. Neurotoxicology 2012, 33:911-924.
37. Verner M.A., Plusquellec P., Muckle G., Ayotte P., Dewailly E., Jacobson S.W., et al. Alteration of infant attention and activity by polychlorinated biphenyls: unravelling critical windows of susceptibility using physiologically based pharmacokinetic modeling. Neurotoxicology 2010, 31:424-431.
38. Vinken M. The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology 2013, 312C:158-165.
39. Watanabe K.H., Andersen M.E., Basu N., Carvan M.J., CroftonF K.M., King K.A., et al. Defining and modeling known adverse outcome pathways: Domoic acid and neuronal signaling as a case study. Environ Toxicol Chem 2011, 30:9-21.
40. Westerink R.H., Ewing A.G. The PC12 cell as model for neurosecretion. Acta Physiol (Oxf) 2008, 192:273-285.
41. Westerink R.H. Exocytosis: using amperometry to study presynaptic mechanisms of neurotoxicity. Neurotoxicology 2004, 25:461-470.
42. 3H]WIN-35,428 binding to the dopamine transporter: a structure-activity relationship study. Neurotoxicology 2013, 10.1016/j.neuro.2013.07.005.
43. Williams E.S., Panko J., Paustenbach D.J. The European Union's REACH regulation: a review of its history and requirements. Crit Rev Toxicol. 2009, 39:553-575.